Onward Medical N.V. Logo

Onward Medical N.V.

ISIN: NL0015000HT4 | Ticker: ONWD | LEI: 9845007A2CC4C8BFSB80
Sector: Health CareSub-Industry: Health Care Technology
Country: Netherlands

About Onward Medical N.V.

Company Description

ONWARD is headquartered in Eindhoven, the Netherlands. It maintains a Science and Engineering Center in Lausanne, Switzerland, and has a growing U.S. presence in Boston, Massachusetts.

Our work builds on decades of research and translational science by giants in this important and emerging field. Our ARC Therapy is designed to deliver targeted, programmed stimulation of the spinal cord to restore movement and other functions in people with spinal cord injury

Year founded

2014

Served area

Worldwide

Headquarters

High Tech Campus 32, 5656 Eindhoven – Netherlands

Financial statements

Download as Excel
Line item in (eur) 01.01.2021 01.01.2022 01.01.2023
Assets N/A 104,796,000.00 76,593,000.00
Noncurrent Assets N/A 12,409,000.00 12,417,000.00
Property Plant And Equipment N/A 190,000.00 415,000.00
Deferred Tax Assets N/A 0.00 163,000.00
Current Assets N/A 92,387,000.00 64,176,000.00
Trade And Other Current Receivables Due From Related Parties N/A 60,000.00 251,000.00
Current Value Added Tax Receivables N/A 339,000.00 709,000.00
Cash and cash equivalents 6,382,000.00 89,443,000.00 41,760,000.00
Shortterm Deposits Not Classified As Cash Equivalents N/A 0.00 20,000,000.00
Current Prepayments And Other Current Assets N/A 2,546,000.00 1,456,000.00
Equity And Liabilities N/A 104,796,000.00 76,593,000.00
Issued Capital N/A 3,622,000.00 3,622,000.00
Retained Earnings N/A -75,974,000.00 -108,319,000.00
Share Premium N/A 155,249,000.00 155,249,000.00
Other Reserves N/A -214,000.00 2,079,000.00
Equity Attributable To Owners Of Parent -32,095,000.00 82,683,000.00 52,631,000.00
Noncurrent Liabilities N/A 16,571,000.00 15,741,000.00
Deferred Tax Liabilities N/A 1,991,000.00 670,000.00
Noncurrent Recognised Liabilities Defined Benefit Plan N/A 1,388,000.00 1,121,000.00
Longterm Borrowings N/A 11,451,000.00 12,656,000.00
Current Liabilities N/A 5,542,000.00 8,221,000.00
Trade And Other Current Payables To Trade Suppliers N/A 952,000.00 1,909,000.00
Other Current Payables N/A 4,034,000.00 5,666,000.00
Current Tax Liabilities Current N/A 83,000.00 219,000.00
Line item in (eur) 01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Profit Loss From Operating Activities -28,532,000.00 -32,028,000.00
Finance Income 0.00 62,000.00
Finance Costs 5,713,000.00 1,572,000.00
Profit Loss Before Tax -34,245,000.00 -33,538,000.00
Income Tax Expense Continuing Operations 69,000.00 -766,000.00
Profit (loss) -34,314,000.00 -32,772,000.00
Profit Loss Attributable To Owners Of Parent -34,314,000.00 -32,772,000.00
Profit Loss Attributable To Noncontrolling Interests 0.00 0.00
Line item in (eur) 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A -34,314,000.00 -32,772,000.00
Adjustments For Unrealised Foreign Exchange Losses Gains N/A -43,000.00 0.00
Adjustments For Sharebased Payments N/A 8,564,000.00 1,691,000.00
Other Adjustments For Noncash Items N/A -2,000.00 106,000.00
Interest Paid Classified As Operating Activities N/A 146,000.00 229,000.00
Interest Received Classified As Operating Activities N/A 0.00 15,000.00
Cash Flows From Used In Operating Activities N/A -19,874,000.00 -26,685,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 91,000.00 386,000.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 2,233,000.00 31,000.00
Cash Flows From Used In Investing Activities N/A -2,324,000.00 -20,417,000.00
Proceeds From Issuing Shares N/A 80,106,000.00 0.00
Proceeds From Borrowings Classified As Financing Activities N/A 30,000,000.00 0.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 144,000.00 557,000.00
Cash Flows From Used In Financing Activities N/A 105,361,000.00 -557,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 83,162,000.00 -47,659,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A -100,000.00 -24,000.00
Cash and cash equivalents 6,382,000.00 89,443,000.00 41,760,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
19.01.23 G.R. Courtine Non-Executive member Other EUR 0.00
03.01.23 D.L. Marver Non-Executive member Other EUR 0.00
23.12.22 F.A. Colen Non-Executive member Other EUR 0.00
18.11.22 D.L. Marver Non-Executive member Other EUR 0.00
29.09.22 V.E. Riefberg Non-Executive member Other EUR 0.00
15.12.21 J.K. Ohrstrom Non-Executive member Other EUR 0.00
22.10.21 D.L. Marver Non-Executive member Other EUR 0.00

Capital markets information

ISIN

NL0015000HT4

LEI

9845007A2CC4C8BFSB80

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Technology

Sub-Industry

Health Care Technology

Listed Stock Exchange

Euronext Amsterdam

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.